BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 3669750)

  • 1. Diagnosis and monitoring in patients with hairy cell leukemia using the monoclonal antibody anti-HC2.
    Berman E; Posnett DN
    Leukemia; 1987 Apr; 1(4):305-7. PubMed ID: 3669750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hairy cell leukemia: a model for studying the B cell family of diseases.
    Al-Katib A; Berman E; Black P; Koziner B
    Semin Oncol; 1986 Dec; 13(4 Suppl 5):48-54. PubMed ID: 3492047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunophenotyping of leukemic cells in the diagnosis of hairy cell leukemia].
    Gotić M; Kraguljac N; RolovićZ ; Radosević N; Bosković D
    Srp Arh Celok Lek; 2000; 128(5-6):157-64. PubMed ID: 11089415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibody B-ly7: a sensitive marker for detection of minimal residual disease in hairy cell leukemia.
    Thaler J; Dietze O; Faber V; Greil R; Gastl G; Denz H; Ho AD; Huber H
    Leukemia; 1990 Mar; 4(3):170-6. PubMed ID: 2314116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An antigen characteristic of hairy cell leukemia cells is expressed on certain activated B cells.
    Posnett DN; Wang CY; Chiorazzi N; Crow MK; Kunkel HG
    J Immunol; 1984 Sep; 133(3):1635-40. PubMed ID: 6431005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin].
    Gotić M; Rolović Z; Radosević N; Draguljac N; Jovanović V; Bogdanović A; Bosković D
    Srp Arh Celok Lek; 2000; 128(7-8):262-70. PubMed ID: 11089434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in peripheral blood and bone marrow specimens during and after alpha 2b-interferon therapy for hairy cell leukemia.
    Bardawil RG; Ratain MJ; Golomb HM; Bitter MA; Groves C; Vardiman JW
    Leukemia; 1987 Apr; 1(4):340-3. PubMed ID: 3669760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance imaging of bone marrow in hairy cell leukemia: correlation with clinical response to alpha-interferon.
    Thompson JA; Shields AF; Porter BA; Olson DO; Rubin E; Kidd P; Fefer A
    Leukemia; 1987 Apr; 1(4):315-6. PubMed ID: 3669752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment.
    Babuŝíková O; Tomová A; Kusenda J; Gyárfás J
    Neoplasma; 2001; 48(5):350-7. PubMed ID: 11845978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of alpha-interferon in the treatment of patients with hairy cell leukemia].
    Gotić M; Rolović Z; Vuković S; Elezović I; Tomić D
    Srp Arh Celok Lek; 1990; 118(7-8):277-84. PubMed ID: 2097776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to interferon-alpha in patients with hairy cell leukemia relapsing after treatment with 2-chlorodeoxyadenosine.
    Seymour JF; Estey EH; Keating MJ; Kurzrock R
    Leukemia; 1995 May; 9(5):929-32. PubMed ID: 7769859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of anti-CD20 monoclonal antibodies (Mabthera) in patients with progressed hairy cell leukemia.
    Lauria F; Lenoci M; Annino L; Raspadori D; Marotta G; Bocchia M; Forconi F; Gentili S; La Manda M; Marconcini S; Tozzi M; Baldini L; Zinzani PL; Foà R
    Haematologica; 2001 Oct; 86(10):1046-50. PubMed ID: 11602410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hairy cell leukemia: an interferon deficient disease?
    Hofmann V; Fehr J; Sauter C; Ottino J
    Cancer Treat Rev; 1985 Dec; 12 Suppl B():33-7. PubMed ID: 3833328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematologic and immunologic changes in hairy cell leukemia patients treated with alpha interferon.
    Turhan AG; Eaves CJ; Connors JM; Eaves AC; Karim KA; Silver KB
    J Biol Regul Homeost Agents; 1988; 2(4):157-65. PubMed ID: 2907963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The beneficial effects of alpha-interferon in hairy cell leukemia are not attributable to NK cell-mediated cytotoxicity.
    Griffiths SD; Cawley JC
    Leukemia; 1987 Apr; 1(4):372-6. PubMed ID: 3669763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hairy cell leukemia: diagnosis using monoclonal antibodies in flow cytometry].
    Viollier AF; Sabo G; Cardile N; Weschler D; Schmidlin C
    Schweiz Med Wochenschr; 1993 Jan; 123(3):61-4. PubMed ID: 7678940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hairy cell leukemia in Japanese patients: a study with monoclonal antibodies.
    Katayama I; Hirashima K; Maruyama K; Hoshino S; Abe T; Furusawa S; Iguchi Y
    Leukemia; 1987 Apr; 1(4):301-5. PubMed ID: 3118108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha interferon for induction of remission in hairy-cell leukemia.
    Quesada JR; Reuben J; Manning JT; Hersh EM; Gutterman JU
    N Engl J Med; 1984 Jan; 310(1):15-8. PubMed ID: 6689734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Monitoring minimal residual disease in patients with hairy cell leukemia in complete remission after treatment with 2-chlorodioxyadenosine].
    Zák P; Chrobák L; Dĕdic K; Podzimek K
    Vnitr Lek; 2000 Oct; 46(10):697-703. PubMed ID: 11344629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pentostatin treatment for hairy cell leukemia patients who failed initial therapy with recombinant alpha-interferon: a report of CALGB study 8515.
    Golomb HM; Dodge R; Mick R; Budman D; Hutchison R; Horning SJ; Schiffer CA
    Leukemia; 1994 Dec; 8(12):2037-40. PubMed ID: 7807991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.